Rite Aid Corp
NYSE:RAD
Rite Aid Corp
NYSE:RAD
Price:
0.1728 USD
-4.95%
Market Closed
Updated:
May 9, 2024
P/B
Price to Book Value
Price to Book Value
-0
Current
-0
Median
1.6
Industry
Lower
than median
Lower
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=-0
Market Cap
/
9.8m
Book Value of Equity
-947.4m
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| US |
|
Rite Aid Corp
NYSE:RAD
|
9.8m USD | -0 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
73B Zac | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.6B Zac | 0 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
14.9B USD | 1.1 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45B BRL | 7.6 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.3B CNY | 4.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
933.5B JPY | 1.8 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.4B MXN | 3.7 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.3B SAR | 7.1 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
588.9B JPY | 2.7 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.2B CNY | 3.7 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
